Achieve Life Sciences (ACHV) FCF Margin Growth (1y) (2011 - 2016)
Achieve Life Sciences (ACHV) FCF Margin Growth (1y) (2011 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 17,483.00 |
| Dec 31, 2015 | 9,215.00 |
| Sep 30, 2015 | -847.00 |
| Jun 30, 2015 | 47,272.00 |
| Mar 31, 2015 | -46,943.00 |
| Dec 31, 2014 | -3,504.00 |
| Sep 30, 2014 | -1,636.00 |
| Jun 30, 2014 | 5,929.00 |
| Mar 31, 2014 | 19,830.00 |
| Dec 31, 2013 | 1,108.00 |
| Sep 30, 2013 | 9,343.00 |
| Jun 30, 2013 | 44,352.00 |
| Mar 31, 2013 | 34,823.00 |
| Dec 31, 2012 | 26,055.00 |
| Sep 30, 2012 | 33,085.00 |
| Jun 30, 2012 | -26,507.00 |
| Mar 31, 2012 | -22,115.00 |
| Dec 31, 2011 | -19,918.00 |
| Sep 30, 2011 | -41,780.00 |